http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104403996-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 |
| filingDate | 2014-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104403996-B |
| titleOfInvention | Human gastric cancer cell line with 5-fluorouracil resistance and establishment method and application thereof |
| abstract | The invention discloses a human gastric cancer cell line with 5-fluorouracil resistance, and an establishment method and application thereof. The human gastric cancer cell line is preserved in China center for type culture Collection with the preservation number of CCTCC NO: 2013154. the human gastric cancer cell line has stable characters, can be stably passed for multiple times, has high tumor formation rate, short incubation period and good uniformity, and provides a new experimental material which is closer to the biological characteristics of clinical tumors for gastric cancer research. The human gastric cancer cell line has tumor formation, and the generated tumor has cisplatin drug resistance, can be used for analyzing in vitro and in vivo drug sensitivity and drug resistance correlation, further establishes in vitro and in vivo two related drug screening platforms, and is an ideal cell line for basic research and clinical early application of human gastric cancer. |
| priorityDate | 2014-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 77.